The Blue Revolution: Jean-Pierre Goux, an inspiring story to reconcile humanity and the biosphere
Interview by Pascale Caron The 23rd Entreprenariales Fair welcomed Jean-Pierre Goux, writer and president of OneHome and Biosphere Economics, for an exceptional conference entitled "The Blue Revolution: how to make the ecological transition desirable and irresistible?". This conference organized by Tribune Côte d'Azur, explored an ambitious project blending science, ecology and collective narrative to transform...
AI Pitfalls: Bias, Hallucinations, and Managerial Implications
Bias, Hallucinations, and Managerial Implications of AI Artificial intelligence, while innovative and promising, has significant limitations that raise ethical, operational, and managerial questions. Among the main challenges are cognitive biases, hallucinations, and organizational impacts related to its adoption. Biases in AI reflect the imperfections of the data and algorithms that process them. Confirmation bias, for...
Laurent Alexandre: The Stakes of Artificial Intelligence in the Era of Technological Disruption
Laurent Alexandre is a French entrepreneur, speaker and essayist, specializing in topics related to technology, artificial intelligence (AI) and biotechnology. A graduate of the École nationale d'administration (ENA), he is also a trained physician, which gives him cross-disciplinary expertise in the fields of health and innovation. Co-founder of Doctissimo in 2000, a major health information...
Cross Data: AI Serving Businesses – Interview with Jean-Charles Rongére
Cross Data supports companies in integrating AI to transform their operations and processes. By leveraging company data and high-performance algorithms, they reveal hidden performance potential. Experts in designing and deploying artificial intelligence solutions, they work in key sectors such as industry, energy, transportation, retail, and healthcare. Their expertise in Machine Learning, Deep Learning, AI Vision,...
Big Pharma and AI: A Revolution Underway in Drug Discovery
Since 2023, the pharmaceutical industry has intensified its commitment to artificial intelligence (AI) to revolutionize drug discovery. The world's 10 largest pharma companies are actively collaborating with AI-specialized startups while developing their own AI-powered discovery engines. This dual strategic movement reflects a unanimous awareness: AI can transform a costly and lengthy process into a faster,...
EntrepreneurIA Interview: Bertrand Charpentier, Co-founder of Pruna AI and the Future of Sustainable AI
Pruna AI was founded in 2023 by Bertrand Charpentier, John Rachwan, Rayan Nait Mazi and Stephan Günnemann. It is a Franco-German startup based in Paris (Station F) and Munich that has just raised $6.5 million in seed funding from EQT Ventures, with participation from Daphni, Motier and Kima Ventures. Backed by recognized figures such as...